Beta-amyloid (Ab) oligomers are strongly associated with the cascade of harmful events leading to neurodegeneration in Alzheimer's disease (AD). Elimination of Ab oligomers or inhibition of Ab assembly is a valuable therapeutic approach for the treatment of AD. Here, we obtained a mimotope of Ab oligomers, AOEP2, by screening a peptide library using oligomer-specific antibodies. The antibodies induced by AOEP2 specifically recognize Ab oligomers rather than monomers and fibrils. Interestingly, the AOEP2 peptide binds to Ab monomers and inhibits the formation of Ab oligomers and b-sheet structure, reduces Ab42-induced neurotoxicity, and decreases the release of proinflammatory cytokines. Taken together, AOEP2, a novel multifunctional peptide directly or indirectly targeting Ab, has promising therapeutic potential for AD.
Ab production, aggregation, cytotoxicity, and clearance [4] , but no agents can be used for AD treatment.
Various vaccines targeting to Ab failed in clinical trials for AD treatment. The first Ab vaccine, AN1792, consisting of Ab42 aggregates was terminated in phase II clinical trials due to the meningoencephalitis with T-cell infiltrates in 6% of immunized AD patients [5] . The following second-generation Ab vaccines, such as ACC-001 and CAD106 using the N-terminal fragments of Ab42 as immunogens did not show therapeutic effect on AD patients [6] . The common features of these vaccines were that their immunogens were derived from Ab42 itself and the induced antibodies targeted to all Ab forms including monomer, oligomer, and fibril, and even APP, which might bring serious side effects and attenuated therapeutic effect. However, an Ab oligomer-specific monoclonal antibody, such as aducanumab, significantly reduced Ab levels in the brains and slowed the clinical recognition declines of AD patients [7] , suggesting that a vaccine or antibody specifically targets Ab oligomers but not Ab monomer or APP may have better therapeutic potentials.
Besides the immunologic agents, some peptides could inhibit Ab aggregation by binding to the central hydrophobic fragment or the C terminus of Ab42, and forming a bulky group that sterically blocked aggregation [8] . These peptides prevented b-sheet formation, inhibited and disaggregated amyloid fibrils, attenuated Ab neurotoxicity in cell culture, reduced Ab plaque deposition, and increased neuronal survival in transgenic mice [9] . However, there are few reports demonstrating that a peptide can act as both epitope of Ab oligomer and inhibitor of b-sheet formation. In this study, we isolated a 12 amino acids peptide (termed AOEP2) from a phage displayed peptide library using oligomer-specific antibodies, and happened to find that AOEP2 not only induced the production of Ab oligomer-specific antibodies but also recognized Ab and inhibited Ab aggregation as a b-sheet inhibitor.
Materials and methods

Materials
Ph.D.
TM -12 Phage Display Peptide Library was obtained from New England Biolabs (Ipswich, MA, USA). Ab42 was purchased from the American Peptide Company (Sunnyvale, CA, USA). The following antibodies were used: IVIG-AOB antibodies [10] (Ab42 oligomer-specific polyclonal antibodies, which was prepared at our laboratory), 4G8 (monoclonal raised against Ab1-16; Signet Laboratories, Covance Research Products, MA, USA), W20 (oligomer-specific single-chain variable fragment, which was developed and prepared at our laboratory), 9E10 (anti-c-Myc antibody; Santa Cruz Biotechnology, Dallas, TX, USA). IL-6 and TNF-a ELISA assay kits were purchased from Neobioscience Co. Ltd. (Beijing, China).
Preparation of Ab monomers, oligomers, and fibrils
Ab42 was dissolved in 100% hexa fluoroisopropanol (HFIP) to a concentration of 1 mgÁmL À1 , sonicated in a water bath for 5 min, aliquoted into microcentrifuge tubes, dried under vacuum, and stored at À20°C. Immediately prior to use, the HFIP-treated Ab42 was dissolved in DMSO to 2 mgÁmL
À1
and diluted to 80 lM in 20 mM pH7.4 PBS buffer (monomer solution) and then incubated at 37°C. The forms of incubated Ab were checked by transmission electron microscope (TEM) and thioflavin T (ThT) dying at different time points, and 2 h-and 7 day-incubated Ab was used as oligomers and fibrils, respectively.
Mouse immunization
The mimotopes were conjugated to keyhole limpet hemocyanin (KLH) using m-maleimidobenzoic acid N-hydroxysuccinimide ester (MBS), respectively. Then, the female Blab/C mice were subcutaneously immunized for two times with 100 lg conjugates (n = 4 for each group) in the presence of aluminum adjuvant. Blood was taken at 2-week intervals; sera was prepared and stored in À80°C until further use. All experimental protocols were approved (reference number was 15-LRT1) by the Tsinghua University Animal Care and Use Committee. Experiments were performed according to the code of practice for animal experimentation of the Animal Welfare Act and the Public Health Service Policy on Laboratory Animal Care.
ELISA
ELISA was used to measure the titers of vaccine-induced antibodies against Ab42 oligomers and mimotope peptides in the sera. Ninety-six-well ELISA plates were coated with antigens overnight at 4°C. After the plates were blocked with 3% (w/v) BSA for 2 h at 37°C, diluted sera were added in triplicates and incubated for 2 h at 37°C. The bound antibodies were detected by adding endo-b-N-acetylglucosaminidase-conjugated anti-mouse antibody and TMB substrate. The enzyme reaction was stopped by adding 2 M H 2 SO 4 , and the OD 450 nm were recorded by microplate reader MD-SpectraMax M5 (Molecular Device, Sunnyvale, CA, USA).
To determine the binding of AOEP2-induced antibodies to different Ab42 forms, samples of Ab42 monomers, oligomers, and fibrils were coated onto 96-well ELISA plates. After blocking, the plate were added with the diluted sera and incubated for 2 h at 37°C and then detected as above mentioned.
ELISA was performed to determine the binding capacity of the synthesized peptide (AOEP2) to the full length of Ab42 peptide. In brief, various concentrations of AOEP2 were coated onto the high-binding polystyrene microtiter plates at 4°C overnight. After blocking, the Ab42 peptide was added and incubated for 2 h 37°C. Anti-Ab42 monoclonal antibody (4G8) was then added and followed by endo-b-N-acetylglucosaminidase-conjugated anti-mouse monoclonal antibody. Conversely, Ab42 at different concentrations were coated onto the plates, and His-tag-conjugated AOEP2 was added and incubated for 2 h at 37°C. Then, anti-His and endo-b-N-acetylglucosaminidase-conjugated monoclonal antibody were used as the detectable antibodies.
To measure Ab42 oligomer levels in Ab42 samples in the absence and presence of AOEP2, Ab42 (20 lM) co-incubated with or without different concentration of AOEP2 (20, 60 , and 200 lM) were coated onto ELISA plates. After blocking, the plates were then incubated with an oligomer-specific scFv antibody W20 or 4G8. Bound W20 and 4G8 were detected using a 1 : 1000 dilution of endo-b-N-acetylglucosaminidaseconjugated 9E10 and endo-b-N-acetylglucosaminidase-conjugated anti-mouse IgG antibodies, respectively.
Dot blot
Dot blot was used to test the binding of AOEP2-induced antibodies to different Ab42 forms. Briefly, samples of Ab42 monomers, oligomers, and fibrils were applied to the membranes and blocked at RT for 1 h with 5% nonfat milk. The membranes were then incubated at room temperature for 1 h with mouse sera diluted in PBST, washed thrice for 10 min each, and incubated with relevant secondary antibodies in PBST for 1 h. The blots were washed thrice and developed with an ECL chemiluminescence kit (Pierce Biotechnology, Rockford, IL, USA).
Dot blot was also applied to determine the binding of AOEP2 peptide to different Ab42 forms. Ab42 monomers, oligomers, and fibrils were spotted onto the membranes and blocked at RT for 1 h with 5% nonfat milk. The membranes were then incubated at room temperature for 1 h with Histag-conjugated peptide of AOEP2, washed thrice for 10 min each, and incubated with anti-his antibodies and relevant secondary antibodies in PBST for 1 h. The blots were washed thrice and developed with an ECL chemiluminescence kit. W20 and 4G8 antibodies were used as positive controls.
Molecular dynamics simulation
Molecular dynamics analysis was performed to determine the interaction between AOEP2 and Ab42. Initially, an unfolded and fully extended structure of Ab42 and AOEP2 was generated by the PROTEIN program in Tinker software (backbone torsion φ, w¼ 135, 135) using AMBER99 force field parameters to assign the atom types. The structure was then optimized by the truncated Newton conjugate gradient method using the GB/SA continuum solvation model. Afterward, 1-ns molecular dynamics stimulation was carried out at a time step of 2.0 fs, and the system thermostat temperature was targeted to 298 K. Docking of the AOEP2 peptide to Ab42 was performed by a customized script using PyRosetta. The result of docking was shown in PYMOL (The PyMOL Molecular Graphics System, Version 1.6, Schro¨din-ger LLC, Cambridge, MA, USA) and further rendered with the POV-RAY program.
Thioflavin T (ThT) fluorescence assay
To determine whether AOEP2 can inhibit Ab aggregation, 20 lM Ab42 was incubated with or without different concentrations (20, 60 , and 200 lM) of AOEP2 peptide. Samples were collected at different time points. The fluorescence was measured with excitation at 450 nm and emission at 480 nm by the Tecan Safire2 microplate reader.
Transmission electron microscope (TEM) imaging
To prepare samples for TEM imaging, 20 lM Ab42 was incubated in the presence or absence of AOEP2 peptide for 8 h at 37°C, and then a 10 lL aliquot of each sample was spotted onto grid and incubated for 20 min. Then, the grid was stained with 10 lL uranyl acetate for 30 s, and the solution was wicked off and then the grid was air-dried. Samples were examined using a Hitachi H7650 transmission electron microscopy (Hitachi, Japan). All images were captured at voltage of 80 kV at instrumental magnification of 50009.
CD spectroscopy
CD spectroscopy was used to detect the Ab42 secondary structure. Ab42 was dissolved in NaOH (40 mM) to 2 mgÁmL À1 and then diluted with PB (50 mM, pH 7.0) to 20 lM. AOEP2 peptide was dissolved with PB (50 mM, pH 7.0) to 10 mgÁmL À1 and added to the above Ab42 solution to the final concentration of 200 lM. Ab42 mixed with or without AOEP2 and AOEP2 alone (200 lM) were incubated for 12 h at 37°C for CD assay. CD measurement was performed on J-810 spectropolarimeter (JASCO, Tokyo, Japan) with a 1-mm path length CD cuvette (Hellma, Forest Hills, NY, USA) containing 200 lL of samples. Spectra were recorded from 190 to 260 nm with a 2-nm bandwidth and 20 nmÁmin À1 scan speed at 22°C. The CD spectra contribution of the incubation buffer was subtracted from that of Ab42 in the absence or presence of AOEP2.
MTT assay
4,5-dimethyl-2-thiazolyl-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay was carried out as previously described. In brief, SH-SY5Y neuroblastoma cells were harvested from flasks and plated in 96-well polystyrene plates with~10 000 cells per well. Ab42 (80 lM, incubated for 2 h) mixed with or without AOEP2 was diluted with fresh medium and added to individual wells. The final concentration of Ab42 in each culture well was 5 lM; the final concentration of AOEP2 in each culture well was 5, 20, or 50 lM, respectively. The plates were then incubated for an additional 48 h at 37°C. Cell viability was determined using an MTT toxicity assay. The absorbance at 570 nm was measured using a microplate reader.
Measurement of TNF-a and IL-6
BV-2 microglial cells were treated with 5 lM Ab42 in the presence or absence of AOEP2. After 12-h incubation, the culture supernatants were collected. The levels of TNF-a and IL-6 released from the activated microglial cells were determined using the TNF-a, IL-6 ELISA kits according to the manufacturer's protocols.
Statistical analysis
Data were obtained from at least three independent experiments for each condition and expressed as mean AE SEM. Statistical significance was analyzed using Student's t-test.
Results
AOEP2 peptide induces Ab42 oligomer-specific antibodies
To obtain a mimotope of Ab oligomers, we screened NEB Ph.D 12 peptide library using oligomer-specific antibody IVIG-AOB. After four rounds of selection, positive clones were picked up and sequenced, and their sequences were analyzed by the BLAST program for homology search. Twenty mimotopes were selected and synthesized, and then coupled to KLH to test the ability to elicit antibodies against the mimotope peptides and Ab42 oligomers. After two times immunization, the antibody levels were measured with the synthetic mimotope peptides and Ab oligomers as the antigens, respectively. All 20 mimotopes induced antibodies against the respective peptide (date not shown), but only one candidate, AOEP2 (FDY-KAEFMPWDT), elicited antibodies recognizing Ab oligomers (Fig. 1A) .
To further determine the specificity of antibody induced by AOEP2, Ab monomers, oligomers, and fibrils were coated onto ELISA plate and incubated with the sera of mice vaccinated with KLH-AOEP2. The results indicated KLH-AOEP2-elicited antibodies specifically bound to Ab oligomers rather than Ab monomers and Ab fibrils (Fig. 1B) . Consistent with ELISA results, the dot-blot results also showed that AOE1 induced-sera strongly bound to Ab oligomers, but not monomers (Fig. 1C,D) . In conjunction with the results of sequence analysis that there was no homology between AOEP2 and Ab42, these results implied that AOEP2 was a spatial mimotope of Ab oligomers.
Binding of AOEP2 peptide to Ab42
ELISA was applied to confirm the binding of AOEP2 to Ab42. The results showed that Ab42 bound to AOEP2 in a concentration-dependent manner ( Fig. 2A) . Consistently, AOEP2 also bound to Ab42 when Ab42 was coated to ELISA plate (Fig. 2B ).
Molecular dynamics analysis was carried out to further investigate the binding sites of AOEP2 to Ab. The results showed that AOEP2 may bound to F20, I31, and V39 of Ab42 monomer by F1, W10, and F7 via hydrophobic interaction (Fig. 2C) .
To further determine the binding of AOEP2 to different Ab forms, Ab monomers, oligomers, and fibrils were spotted onto the nitrocellulose membrane and incubated with the Hig-tagged AOEP2 peptide. The results showed that AOEP2 simultaneously bound to Ab monomers, oligomers, and fibrils (Fig. 2D) .
AOEP2 peptide inhibits Ab42 aggregation
The fluorescence emission of ThT is shifted when ThT binds to b-sheet structure of aggregation. Ab42 alone Fig. 2 . Binding of AOEP2 to Ab42. (A) Binding of Ab42 to AOEP2 was tested via ELISA. Ab42 or PBS was added to ELISA plates coated with different concentrations of AOEP2 peptide. Bound Ab42 was detected using 4G8 monoclonal antibody and endo-b-N-acetylglucosaminidaseconjugated anti-mouse antibody (compared with PBS control, **P < 0.01). (B) Binding of AOEP2 to Ab42 was tested via ELISA. AOEP2 peptide with His tag or PBS was added to ELISA plates coated with different concentrations of Ab42. Bound AOEP2 was detected using anti-His monoclonal antibody and endo-b-N-acetylglucosaminidase-conjugated anti-mouse antibody (compared with PBS control, **P < 0.01). (C) Molecular interaction between Ab42 and AOEP2. Molecular dynamics simulation was applied to docking of AOEP2 to Ab42 by a customized script using PyRosetta. 1-ns molecular dynamics stimulation was carried out at a time step of 2.0 fs. The structure of AOEP2 peptide are indicated in the top or bottom corner of each figure (hydrophobic amino acids are indicated in red). (D) Ab42 monomers, oligomers, and fibrils were spotted onto nitrocellulose membrane. The biding of AOEP2 to different Ab forms were detected by dot blot.
showed the expected time-dependent increase in inflorescence. However, Ab42 co-incubated with AOEP2 showed lower b-sheet growth rates. Ab42 fibril formation was inhibited by~20% by 20 lM AOEP2,~50% by 60 lM AOEP2, and more than 70% by 200 lM AOEP2, respectively (Fig. 3A) .
The morphologies of the Ab42 samples incubated with or without AOEP2 for 10 h were determined by TEM. Consistent with the ThT results, Ab42 alone formed numerous long fibrils while Ab42 incubated with 20 lM AOEP2 formed fewer fibrils. There were a few short fibrils, and numerous oligomers were observed in the Ab sample incubated with 60 lM AOEP2, and only numerous oligomers were observed when Ab incubated with 200 lM AOEP2 (Fig. 3B) .
The formation of b-sheet is a crucial step in Ab fibrillation. To investigate the effect of AOEP2 on the conformational conversion of Ab42, representative CD spectra of Ab42 co-incubated with or without AOEP2 for 12 h were analyzed. Ab42 undergoes conformational changes from random coil/a-helix to b-sheet structure during aggregation process. The CD spectra of Ab42 after incubation displayed a strong positive peak and a negative peak at around 195 and 220 nm, respectively (Fig. 3C,D) . However, the typical CD spectra of b-sheet of Ab42 were impaired by AOEP2 treatment. These results indicated that AOPE2 inhibited Ab fibrillation by reducing b-sheet structure formation.
To further investigate the effect of AOEP2 on Ab42 aggregation, Ab42 pre-incubated with or without , and 200 lM AOEP2 for 0 and 12 h, and then coated onto a 96-well plate. W20 (E) and 4G8 (F) as the primary antibody was added, followed by the addition of secondary antibodies, respectively. The absorbance was measured at 450 nm. Each assay was performed in triplicate (compared with Ab alone, *P < 0.05).
AOEP2 was applied for ELISA analysis. Ab oligomer levels were detected with the oligomer-specific antibody W20 and the total Ab levels were detected with 4G8 as a control. The results indicated that AOEP2 (60 lM and 200 lM) significantly decreased W20-recognized Ab42 oligomer levels after 12 h incubation (Fig. 3E) but did not decrease the levels of total Ab (Fig. 3F) . These results indicate that AOEP2 as a b-sheet inhibitor inhibited the formation of Ab fibril and some types of oligomers.
Peptide AOEP2 attenuates Ab42 cytotoxicity
MTT assay is widely used to determine cell viability and cellular response to Ab. To determine the effect of peptide AOEP2 on Ab-mediated cellular toxicity, neuroblastoma SH-SY5Y cells were treated with aggregated Ab42 in the absence or presence of AOEP2. The results showed that 5 lM Ab42 remarkably reduced cell viability, whereas AOEP2 attenuated Ab42-induced cytotoxicity in a concentration-dependent manner. 50 lM AOEP2 inhibited Ab42-induced cytotoxicity by 90% at 48 h after AOEP2 addition (Fig. 4A) .
AOEP2 reduces the Ab42-induced production of TNF-a and IL-6 in vitro
Inflammation is important for the pathogenesis of AD. We analyzed the production of Ab42-induced proinflammatory cytokines including TNF-a and IL-6 in BV-2 microglial cells in the absence or presence of AOEP2. The levels of TNF-a and IL-6 were remarkably increased when 5 lM Ab42 was added, while AOEP2 significantly decreased TNF-a and IL-6 production in a dose-dependent manner (Fig. 4B,C) .
Discussion
Among various Ab forms, the soluble oligomeric forms are the most neurotoxic and closely related to the pathology of AD, while Ab monomer and APP are involved in the development and plasticity of the nervous system [11] . Therefore, elimination of toxic Ab species by antibodies and vaccines or inhibition of Ab aggregation by some agents are promising strategies for the prevention and treatment of AD [7, 12] . Many vaccines against Ab had been clinically tested. However, none of them was successfully developed to rescue the memory deficits of AD patients in Phase III clinical trials [13] . These vaccines applied the full length or N-terminal of Ab peptide as the immunogen, which elicited antibodies recognizing all forms of Ab and APP and might trigger an autoimmune response [14, 15] . Thus, a vaccine with an immunogen that elicit antibodies specifically against Ab oligomers rather than monomers may have better therapeutic potentials. A previous report showed a mimotope peptide of Ab42 fibrils and induced anti-Ab42 fibril antibodies by displaying the mimotope on a carrier [16] . In this study, we isolated the mimotope of Ab oligomers which elicited oligomer-specific antibodies. The fact that there was no sequence homology between AOEP2 and Ab42 suggested that AOEP2 was a specific mimotope of Ab42 oligomer.
The 'like-interaction-like' hypothesis indicated that a peptide fragment or analogs derived from their parent amyloid protein might inhibit the folding and aggregation of amyloid peptides [17] . Consistent with this hypothesis, AOEP2, as an analog of Ab oligomer, was able to bind with Ab and block Ab aggregation, which was confirmed by our ELISA and molecular dynamic analysis results. The hydrophobic C-terminal residues of Ab are necessary in Ab aggregation as they have higher propensity to form ordered b-sheet structure than the N-terminal residues of Ab [18] . The central hydrophobic core of Leu17-Ala21 (LVFFA) is another critical region involved in Ab aggregation [19, 20] . Disruption of the C-terminal or central region of Ab42 with peptides interfered with Ab aggregation and neurotoxicity [21, 22] . AOEP2 simultaneously bound to the C-terminal (V39) and central hydrophobic core (F20) of Ab42, exhibiting excellent inhibitory effect for Ab42 aggregation. Our ThT staining, TEM, and CD results also confirmed that AOEP2 significantly inhibited fibril formation of Ab42. The driving forces governing the b-assembly may include hydrophobic forces and hydrogen bonding. The Ab16-20 fragment (KLVFF) inhibited the aggregation of Ab predominantly by the hydrophobic force formed between two peptides [22] . Similarly, the hydrophobic force between AOEP2 and Ab42 was also the major factor in the inhibition of Ab aggregation.
Inhibition of Ab aggregation may simultaneously alter the conformation of Ab and reduce Ab oligomerinduced cytotoxicity [23] . Our results showed that AOEP2 inhibited Ab aggregation but did not decrease the oligomer formation. Nevertheless, AOEP2 decreased Ab42 cytotoxicity, which may be because AOEP2 transferred Ab42 oligomers to harmless types. This speculation was confirmed by the result that AOEP2 decreased the level of detrimental oligomers recognized by W20. Previous work demonstrated that the substitution of I31 with proline completely altered the neurotoxic properties of Ab42 [24] , and the interaction of I31 with M35 may play an important role in the oxidative processes of M35, which contributed to the toxicity of Ab42. The binding of AOEP2 to I31 of Ab42 might destroy the interaction of I31 with M35 and transform the Ab42 conformation into a harmless structure [25] , implying that AOEP2 inhibited Ab42-induced cytotoxicity by a mechanism of more than the inhibition of Ab42 aggregation. Neuroinflammation induced by activated microglia and astrocytes contributed to the neuronal damage and processing of AD [26] . The proinflammatory cytokines released by activated glial cells, such as TNF-a and IL-6, could promote Ab production and induce neuronal apoptosis [27] . In this study, AOEP2 significantly decreased the levels of TNF-a and IL-6 released by BV-2 cells in a dose-dependent manner, suggesting that AOEP2 may also provide neuroprotection by reducing inflammation.
In conclusion, AOEP2 peptide as a mimotope of Ab oligomer elicited antibodies specifically recognizing Ab oligomers, whereas AOEP2 peptide as a b-sheet inhibitor also directly inhibited Ab42 aggregation and reduced Ab-induced cytotoxicity and the production of proinflammatory cytokines (Fig. 4D) . Such a multifunctional peptide directly or indirectly targeting Ab may be a promising therapeutic approach for the treatment of AD. Fig. 4 . AOEP2 inhibits Ab42-induced cytotoxicity and the production of proinflammatory cytokines. (A) Ab42 mixed with or without different concentrations of AOEP2 was added to SH-SY5Y neuroblastoma cells and incubated for 48 h. Cell viability was measured using MTT assay. The data shown are expressed as the percentage of control values from three independent experiments. (B,C) The effect of AOEP2 on the production of TNF-a (B) and IL-6 (C). BV-2 cells were treated with Ab42 in the presence or absence of 5, 20, or 50 lM AOEP2 for 12 h. The supernatants were collected and the levels of TNF-a and IL-6 were determined using the ELISA kit (compared with Ab42 alone, *P < 0.05, **P < 0.01). (D) Schematic illustration of AOEP2s function. AOEP2 peptide as a mimotope of Ab42 oligomers induces the production of antibodies specifically recognizing Ab42 oligomers. Simultaneously, AOEP2 peptide binds to Ab42 monomer and inhibits Ab aggregation.
